Synthesis, characterization, In-Silico studies, and anti-inflammatory activity of Novel Imidazole-5(4H)-Ones

https://doi.org/10.53730/ijhs.v6nS1.6445

Authors

  • G. Muthuboopathi Department of Pharmaceutics, School of Pharmaceutical Sciences, Vels Institute of Science, Technology & Advanced Studies (VISTAS), Chennai, 600117, Tamil Nadu, India
  • T. S. Shanmugarajan Department of Pharmaceutics, School of Pharmaceutical Sciences, Vels Institute of Science, Technology & Advanced Studies (VISTAS), Chennai, 600117, Tamil Nadu, India

Keywords:

Imidazole, Benzylidene, Furan, In-silico studies, Molecular docking, Anti-inflammatory

Abstract

Several new imidazole-5(4H)-one analog was synthesized using multi-step synthesis. All the synthesized compounds were characterized using FT-IR, 1H-NMR, Mass spectroscopy, and microanalysis to confirm their chemical structure. Molecular properties of the title compounds were predicted using Molinspiration online tool and binding studies of the title analogs against COX-1 & COX-2 were predicted by the molecular docking method. All novel imidazole-5(4H)-one analog were tested for their in-vivo anti-inflammatory activity using carrageenan-induced paw edema test in Wistar rats. Varying degree (weak to excellent) of anti-inflammatory activity was displayed by title compounds. In addition, in vitro anticancer potency of test compounds was estimated by the MTT assay method and found that most of the tested analogs were found to be inactive at 10 µM concentration against the tested cell lines. Among twelve tested title compounds, 2-methyl-1-(4-methyl piperazine-1-yl)-4-(naphthalen-1-ylmethylene)-1H-imidazol-5(4H)-one AL01, and 4-benzylidene-2-methyl-1-(4-methylpiperazin-1-yl)-1H-imidazol-5(4H)-one AL02 displayed more potent anti-inflammatory activity which is slightly higher than reference diclofenac.

Downloads

Download data is not yet available.

References

S.V. Bhandari, S.C. Dangre, K.G. Bothara, A.A. Patil, A.P. Sarkate and D.K. Lokwani, Eur. J. Med. Chem.,44, 4622 (2009).

G. Dannhardt and W. Kiefer, Eur. J. Med. Chem.,36, 109 (2001).

S. Saravanan, P.S. Selvan, N. Gopal, J.K. Gupta, and B. De,Archiv der Pharmazie: An International Journal Pharmaceutical and Medicinal Chemistry, 338(10), 488 (2005).

A. Siwach, P.K. Verma,BMC Chemistry, 15, 12 (2021).

L.H. Al-Wahaibi, B.G. Youssif, E.S. Taher, A.H. Abdelazeem, A.A. Abdelhamid, and A.A. Marzouk, Molecules, 26(16), 4718 (2021).

C. Bamoro, F. Bamba, K.T.D. Steve-Evanes, V. Aurélie, and C. Vincent, Open Journal of Medicinal Chemistry, 11(2), 17 (2021).

C.M. Gallati, S.K. Goetzfried, M. Ausserer, J. Sagasser, M. Plangger, K. Wurst, M. Hermann, D. Baecker, B. Kircher, and R. Gust, Dalton Transactions, 49(17), 5471 (2020).

A. Valls, J.J. Andreu, E. Falomir, S.V. Luis, E. Atrián-Blasco, S.G. Mitchell, and B. Altava, Pharmaceuticals, 13(12), 482 (2020).

S.S. Alghamdi, R.S. Suliman, K. Almutairi, K. Kahtani, and D. Aljatli, Drug Design, Development, and Therapy, 15, 3289 (2021).

J.G. Lombardino, and E.H. Wiseman, Journal of Medicinal Chemistry, 17(11), 1182 (1974).

A.K. Gopalakrishnan, S.A. Angamaly,and M.P. Velayudhan, ChemistrySelect, 6(40), 10918 (2021).

M. Bian, Q.Q. Ma, Y. Wu, H.H. Du, and G. Guo-Hua, Journal of Enzyme Inhibition and Medicinal Chemistry, 36(1), 2139 (2021).

A. Verma, S. Joshi, and D. Singh, Journal of Chemistry, (2013).

X.L. Ma, C. Chen, and J. Yang, Acta Pharm Sin, 26(4), 500 (2005).

R. Mannhold,. Molecular drug properties-Measurement and prediction. Wiley-VHC Verlag GmbH & Co. KGaA: Weinheim, Germany, 30, (2008).

Y.H. Zhao, J. Le, M.H. Abraham, A. Hersey, P.J. Eddershaw, C.N. Luscombe, D. Boutina, G. Beck, B. Sherborne, I. Cooper, and J.A. Platts, J. Pharm. Sci.,90(6), 749(2001).

C. Björkelid, T. Bergfors, A.K.V. Raichurkar, K. Mukherjee, K. Malolanarasimhan, B. Bandodkar, and T.A. Jones, J. Biol. Chem., 288(25), 18260 (2013).

S.M. Batt, T. Jabeen, V. Bhowruth, L. Quill, P.A. Lund, L. Eggeling, L.J. Alderwick, K. Fütterer, and G.S. Besra, Proceedings of the National Academy of Sciences,109(28), 11354 (2012).

A. Wehenkel, P. Fernandez, M. Bellinzoni, V. Catherinot, N. Barilone, G. Labesse, M. Jackson, and P.M. Alzari, FEBS letters, 580(13), 3018 (2006).

S.R. Luckner, C.A. Machutta, P.J. Tonge, and C. Kisker, Structure, 17(7), 1004 (2009).

X.Y. Meng, H.X. Zhang, M. Mezei, and M. Cui, Curr. Comput. Aided Drug Des., 7(2), 146 (2011).

E.D. Olfert, B.M. Cross, andA.A. McWilliam, Canadian council of animal care guide to the care and use of experimental animals, Vol 1, 2nd edn (1993).

C.A. Winter, E.A. Risley, and G.W. Nuss, Exp. Biol. Med.,111, 544 (1962).

Published

30-04-2022

How to Cite

Muthuboopathi, G., & Shanmugarajan, T. S. (2022). Synthesis, characterization, In-Silico studies, and anti-inflammatory activity of Novel Imidazole-5(4H)-Ones. International Journal of Health Sciences, 6(S1), 6816–6834. https://doi.org/10.53730/ijhs.v6nS1.6445

Issue

Section

Peer Review Articles